The use of a new model for the investigation of sepsis

Acta Veterinaria

Volumn 52, Issue 2-3, 2002, Pages 125-132

  Stojanović, Dragica ^a   Malicevic Z ^a   Ružica, Ašanin ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

E.coli; Rat; Sepsis; Staph. aureus

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD ANALYSIS; BLOOD SAMPLING; CECUM; CLINICAL FEATURE; CONTROLLED STUDY; INOCULATION; MALE; NONHUMAN; PARENCHYMA; RAT; SEPSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ESCHERICHIA COLI; MIRABILIS; NEGIBACTERIA; POSIBACTERIA; PROTEUS MIRABILIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0036408837     PISSN: 05678315     EISSN: None     Source Type: Journal    
DOI: 10.2298/avb0203125s     Document Type: Article

References (20)

1. Beutler B, 1993, Endotoxin, tumor necrosis factor, and related mediators: New approaches to shock, New Horiz, 1, 3-12.
2. Bone RC, 1991, The pathogenesis of sepsis. Ann Intern Med, 115(6): 457-69.
3. Bone RC, 1996, Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation, Crit Care Med, 24, 163-72.
4. Casey LC, Balk RA, Bone RC, 1993, Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome, Ann Intern Med, 119, 771-8.
5. Fink MP, Heard SO, 1990, Laboratory models of sepsis and septic shock., J Surg Res, 49,186-96.
6. Hackett S, Stevens DL, 1993, Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis, J Infect Dis, 168: 232-5.
7. Johnston JD, Harvey CJ, Menzies IS, Treacher DF, 1996, Gastrointestinal permeability and absorptive capacity in sepsis, Crit Care Med, 24: 1144-9.
8. Lang CH, Bagby GJ, Bornside GH, Vial JL, Spitzer JJ, 1983. Sustained hypermetabolic sepsis in rats: Characterization of the model, J Surg Res, 359, 201-10.
9. Lang CH, Bagby GJ, Blakesley HL, Spitzer JJ, 1987. Fever is not responsible for the elevated glucose kinetics in sepsis, Proc Soc Exp Biol Med, 185, 455-61.
10. Parrillo JE, Pathogenetic mechanisms of septic shock, 1993, N Engl J Med. 328, 1471-7.
11. Piper RD, Cook D, Bone RC, Sibbald W, 1996, Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis, Crit Care Med, 24(12): 2059-70.
12. Remick DG, Kunkel SL, 1993, Pathophysiologic alterations induced by tumor necrosis factor, Int Rev Exp Pathol, 34(Pt 3): 7-25.
13. Rixen D, Siegel JH, Phil FM, 1996, "Sepsis/SIRS," Physiologic classification, severity stratification, relation to cytokine elaboration and outcome prediction in posttrauma critical illness, J Trauma, 41, 581-98.
14. Schletter M, Heine H, 1995, Molecular mechanisms of endotoxin activity, Arch Microbiol, 164, 383-9.
15. Shapiro L, Gelfand JA, 1993, Cytokines and sepsis: Pathophysiology and therapy. New Horiz, 1, 13-22.
16. Sibbald WJ, Marshall J, 1991, "Sepsis"-Clarity of existing terminology ... or more confusion? Crit Care Med, 19, 996-8.
17. Talan DA, 1993, Recent developments in our understanding of sepsis: Evaluation of anti-endotoxin antibodies and biological response modifiers. Ann Emerg Med, 22, 1871-90.
18. Vander Meer TJ, Wang H, Fink MP, 1995.Endotoxemia causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock, Crit Care Med, 23, 1217-26.
19. Waymack JP, Guzman RF, Mason AD, Pruitt BA, 1990, Effect of prostaglandin E in multiple experimental models. VII. Effect on resistance to sepsis, Burns, 16, 9-12.
20. Wichterman KA, Baue AE, Chaudry IH, 1980, Sepsis and septic shock-A review of laboratory models and a proposal, J Surg Res, 29, 189-201.